Literature DB >> 36118545

The clinical course of interstitial lung disease in an adult patient with an ABCA3 homozygous complex allele under hydroxychloroquine and a review of the literature.

Marie Legendre1,2, Xavier Darde3, Marion Ferreira3,4, Sandra Chantot-Bastaraud2,5, Marion Campana6, Laurent Plantier3,4, Nadia Nathan2,7, Serge Amselem2,2, Annick Toutain8,9, Patrice Diot3,4, Sylvain Marchand-Adam3,4.   

Abstract

OBJECTIVE: The gene mutations responsible for ABCA3 protein deficiency are involved in respiratory distress of the newborn and much more rarely in adult interstitial lung diseases (ILD). An adult patient homozygous for a complex allele encompassing the p.Ala1027Pro likely pathogenic mutation and the p.Gly974Asp variation was followed for a late-onset and fibrotic ILD. The evolution was marked by progressive clinical and functional degradation despite corticosteroid pulses. The patient, who was first registered on the list for lung transplantation, was improved quickly and persistently for at least 6.5 years with hydroxychloroquine treatment, allowing removal from the transplant list.

Entities:  

Keywords:  ABCA3; Hydroxychloroquine; ILD

Year:  2022        PMID: 36118545      PMCID: PMC9437752          DOI: 10.36141/svdld.v39i2.12730

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   1.803


  16 in total

1.  Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children.

Authors:  Florence Flamein; Laure Riffault; Céline Muselet-Charlier; Julie Pernelle; Delphine Feldmann; Laurence Jonard; Anne-Marie Durand-Schneider; Aurore Coulomb; Michèle Maurice; Lawrence M Nogee; Nobuya Inagaki; Serge Amselem; Jean Christophe Dubus; Virginie Rigourd; François Brémont; Christophe Marguet; Jacques Brouard; Jacques de Blic; Annick Clement; Ralph Epaud; Loïc Guillot
Journal:  Hum Mol Genet       Date:  2011-11-07       Impact factor: 6.150

2.  [Lung diseases associated with inherited disorders of surfactant metabolism].

Authors:  R Epaud; D Feldmann; L Guillot; A Clément
Journal:  Arch Pediatr       Date:  2008-09-19       Impact factor: 1.180

3.  ABCA3 mutations associated with pediatric interstitial lung disease.

Authors:  Janine E Bullard; Susan E Wert; Jeffrey A Whitsett; Michael Dean; Lawrence M Nogee
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

4.  Lung disease caused by ABCA3 mutations.

Authors:  Carolin Kröner; Thomas Wittmann; Simone Reu; Veronika Teusch; Mathias Klemme; Daniela Rauch; Meike Hengst; Matthias Kappler; Nazan Cobanoglu; Tugba Sismanlar; Ayse T Aslan; Ilaria Campo; Marijke Proesmans; Thomas Schaible; Susanne Terheggen-Lagro; Nicolas Regamey; Ernst Eber; Jürgen Seidenberg; Nicolaus Schwerk; Charalampos Aslanidis; Peter Lohse; Frank Brasch; Ralf Zarbock; Matthias Griese
Journal:  Thorax       Date:  2016-08-11       Impact factor: 9.139

Review 5.  ABCA3 mutations in adult pulmonary fibrosis patients: a case series and review of literature.

Authors:  Dymph Klay; Mark G J P Platenburg; Rein H N A J van Rijswijk; Jan C Grutters; Coline H M van Moorsel
Journal:  Curr Opin Pulm Med       Date:  2020-05       Impact factor: 3.155

6.  Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood.

Authors:  Effrosyni D Manali; Marie Legendre; Nadia Nathan; Caroline Kannengiesser; Aurore Coulomb-L'Hermine; Theofanis Tsiligiannis; Pericles Tomos; Matthias Griese; Raphael Borie; Annick Clement; Serge Amselem; Bruno Crestani; Spyros A Papiris
Journal:  ERJ Open Res       Date:  2019-07-22

Review 7.  Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.

Authors:  Seidu A Richard; Sylvanus Kampo; Maite Esquijarosa Hechavarria; Marian Sackey; Alexis D B Buunaaim; Eugene Dogkotenge Kuugbee; Thomas Winsum Anabah
Journal:  J Immunol Res       Date:  2020-09-25       Impact factor: 4.818

8.  The common ABCA3E292V variant disrupts AT2 cell quality control and increases susceptibility to lung injury and aberrant remodeling.

Authors:  Yaniv Tomer; Jennifer Wambach; Lars Knudsen; Ming Zhao; Luis R Rodriguez; Aditi Murthy; Frances V White; Alessandro Venosa; Jeremy Katzen; Matthias Ochs; Aaron Hamvas; Michael F Beers; Surafel Mulugeta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-06-16       Impact factor: 6.011

9.  A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant.

Authors:  Ilaria Campo; Michele Zorzetto; Francesca Mariani; Zamir Kadija; Patrizia Morbini; Roberto Dore; Eva Kaltenborn; Sabrina Frixel; Ralf Zarbock; Gerhard Liebisch; Jan Hegermann; Christoph Wrede; Matthias Griese; Maurizio Luisetti
Journal:  Respir Res       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.